Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Opus Genetics Inc shares valued at $8,600,000 were sold by Foundation Fighting Blindness on Dec 09 ’25. At $2.15 per share, Foundation Fighting Blindness sold 4,000,000 shares. The insider’s holdings dropped to 5,492,171 shares worth approximately $11.2 million following the completion of this transaction.
Also, Magrath George purchased 100,000 shares, netting a total of over 97,600 in proceeds. Following the buying of shares at $0.98 each, the insider now holds 599,150 shares.
As published in their initiating research note from B. Riley Securities on December 10, 2025, Opus Genetics Inc [IRD] has been a Buy and the price target has been revised to $9. Analysts at Piper Sandler started covering the stock with ‘”an Overweight”‘ outlook in a report released in late November. As of October 29, 2025, Wedbush has initiated its “an Outperform” rating for IRD. Earlier on October 16, 2025, Chardan Capital Markets initiated its rating. Their recommendation was “a Buy” for IRD stock.
Analyzing IRD Stock Performance
On last trading session, Opus Genetics Inc [NASDAQ: IRD] rose 1.49% to $2.04. The stock’s lowest price that day was $2.0, but it reached a high of $2.09 in the same session. During the last five days, there has been a surge of approximately 0.99%. Over the course of the year, Opus Genetics Inc shares have jumped approximately 108.48%. Shares of the company reached a 52-week high of $2.59 on 12/10/25 and a 52-week low of $0.65 on 04/10/25.
Support And Resistance Levels for Opus Genetics Inc (IRD)
According to the 24-hour chart, there is a support level at 1.99, which, if violated, would cause prices to drop to 1.93. In the upper region, resistance lies at 2.09. The next price resistance is at 2.14. RSI (Relative Strength Index) is 47.20 on the 14-day chart, showing neutral technical sentiment.
Is Opus Genetics Inc subject to short interest?
Stocks of Opus Genetics Inc saw a sharp rise in short interest on 2025-11-28 jumping by 82331.0 shares to 0.58 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 0.5 million shares. A jump of 14.16% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 1.08 of the overall float, the days-to-cover ratio (short ratio) jumped to 1.08.
Which companies own the most shares of Opus Genetics Inc (IRD)?
In terms of Opus Genetics Inc share price expectations, FactSet research, analysts set an average price target of 7 in the next 12 months, up nearly 248.26% from the previous closing price of $2.01. Analysts anticipate Opus Genetics Inc stock to reach 7 by 2025, with the lowest price target being 7. On April 11, 2025, Craig Hallum assigned a price target of “a Buy” to the stock and initiated coverage with a $6.
